A new platform for advanced proton therapy in lung cancer treatment
Open IPO and QA platform for conformal FLASH proton therapy
This study is looking at a new way to make proton therapy for central lung cancer safer and more effective, so patients can get better treatment with fewer side effects.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11122784 on NIH RePORTER |
What this research studies
This research focuses on improving proton therapy for central lung cancer by developing an innovative platform that optimizes treatment delivery. It aims to reduce damage to surrounding healthy organs while effectively targeting tumors. The approach combines advanced techniques to minimize toxicity and enhance the immune response, addressing critical challenges in current treatment methods. Patients may benefit from a more effective and safer treatment option that reduces the risk of severe side effects.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with central lung cancer who are seeking advanced treatment options.
Not a fit: Patients with lung cancer types that do not involve central lesions or those who are not candidates for proton therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide lung cancer patients with a safer and more effective treatment option that minimizes damage to healthy tissues.
How similar studies have performed: Other research has shown promise in using advanced proton therapy techniques, but this specific approach is innovative and largely untested.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Lin, Liyong — Emory University
- Study coordinator: Lin, Liyong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.